CAS 1802175-07-0

(R)-1-(1-(1-(Ethylsulfonyl)piperidin-4-yl)ethyl)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1H-indole-3-carboxamide

CAS: 1802175-07-0

Formula: C₂₇H₃₆N₄O₅S

Molecular weight: 528.6635

Ref: IN-DA0021SC

CPI-169 R-enantiomer

Controlled Product

CAS: 1802175-07-0

CPI-169 is a drug that belongs to the class of histone lysine methyltransferase inhibitors. It has been shown to be effective in vivo in models of cancer and hyperactivity. CPI-169 also inhibits the production of suppressor genes and activates constitutive gene expression by inhibiting the methylation of histones H3 and H4. This results in a modification of the immune microenvironment to induce an anti-tumour response, which may be useful for treating patients with cancer or autoimmune diseases.

Formula: C₂₇H₃₆N₄O₅S

Purity: Min. 95%

Molecular weight: 528.66 g/mol

Ref: 3D-FC137666